1-3 of 3
Lizheng Shi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Overall Survival of Patients with Chronic Lymphocytic Leukemia Treated with Frontline Bruton's Tyrosine Kinase Inhibitors: An Analysis of the United States Veterans Health Administration Database

Lindsey Fitzgerald, Wasiulla Khan, Alex Bokun, Angela Lax, Fan Mu, Yilu Lin, Lizheng Shi, Zaina P Qureshi, Solomon Graf
Journal: Blood
Blood (2024) 144 (Supplement 1): 7753.
https://doi.org/10.1182/blood-2024-201206
Published: 2024
Journal Articles

Mortality Among Veterans with a Diagnosis of Pyruvate Kinase (PK) Deficiency: A Real-World Study Using US Veterans Health Administration Data

Erin Zagadailov, PharmD, Audra Boscoe, PhD, Viviana Garcia-Horton, PhD, Sherry Shi, MSc, Shuqian Liu, MD, Lizheng Shi, PhD, Dendy Macaulay, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-136693
Published: 2020
Journal Articles

Comparable Overall Survival with Rituximab-Bendamustine (R-Benda) and Rituximab-Gemcitabine-Oxaliplatin (R-GemOx) When Used As Second-Line (2L) Treatment for Diffuse Large B-Cell Lymphoma (DLBCL): A Real-World Study Using US Veterans Health Administration Data

Raluca Ionescu-Ittu, PhD, Aijing Shang, Nancy Vander Velde, Annie Guérin, Yilu Lin, Lizheng Shi, Sherry Shi, Naseer Qayum
Journal: Blood
Blood (2018) 132 (Supplement 1): 1711.
https://doi.org/10.1182/blood-2018-99-113039
Published: 2018